{"id":"NCT01830855","sponsor":"Pfizer","briefTitle":"A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged â‰¥10 to <19 Years","officialTitle":"A Phase 3, Randomized, Active-controlled, Observer-blinded Trial To Assess The Lot Consistency, Safety, Tolerability, And Immunogenicity Of A Meningococcal Serogroup B Bivalent Rlp2086 Vaccine In Healthy Subjects Aged >/=10 To <19 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04","primaryCompletion":"2015-04","completion":"2015-04","firstPosted":"2013-04-12","resultsPosted":"2016-06-14","lastUpdate":"2016-06-14"},"enrollment":3596,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Vaccine"],"interventions":[{"type":"BIOLOGICAL","name":"rLP2086","otherNames":[]},{"type":"BIOLOGICAL","name":"rLP2086","otherNames":[]},{"type":"BIOLOGICAL","name":"rLP2086","otherNames":[]},{"type":"BIOLOGICAL","name":"Havrix (HAV)","otherNames":[]},{"type":"BIOLOGICAL","name":"Saline","otherNames":[]}],"arms":[{"label":"rLP2086 lot 1","type":"EXPERIMENTAL"},{"label":"rLP2086 lot 2","type":"EXPERIMENTAL"},{"label":"rLP2086 lot 3","type":"EXPERIMENTAL"},{"label":"Control","type":"ACTIVE_COMPARATOR"}],"summary":"This study is looking at a new vaccine that might prevent meningococcal disease, and will study whether healthy adolescent subjects receiving different lots of vaccine respond in a similar way. The study will also look at the safety of the new vaccine as well as how it is tolerated.","primaryOutcome":{"measure":"Percentage of Participants With >=4 Fold Rise in Serum Bactericidal Assay Using Human Complement (hSBA) for 4 Primary Strains and Composite Response (hSBA >=Lower Limit of Quantification [LLOQ] for All 4 Primary Strains Combined) for Group 1","timeFrame":"One month after third bivalent rLP2086 vaccination","effectByArm":[{"arm":"Group 1 rLP2086 Lot 1","deltaMin":83.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":99,"countries":["United States","Canada","Czechia","Finland","Germany","Italy","Poland","United Kingdom"]},"refs":{"pmids":["35164991","32700260","32681472","29236639"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1971009&StudyName=A%20trial%20to%20assess%20the%20lot%20consistency%2C%20safety%2C%20tolerability%20and%20immunogenicity%20of%20bivalent%20rLP2086%20vaccine%20when%20given%20to%20healthy%20sub"]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":1508},"commonTop":["Pain at injection site -Any (reactogenicity event)","Headache -Any (reactogenicity event)","Fatigue -Any (reactogenicity event)","Muscle pain -Any (reactogenicity event)","Chills-Any (reactogenicity event)"]}}